Kepley, Christopher L.
Wang, Yinghui
Yelton, Amy
Siebert, Eva R.
Iweala, Onyinye I.
Funding for this research was provided by:
NCI (R15CA246430)
NIH NIAID (K08 AI141691)
2020 American Association of Allergy, Asthma, and Immunology Foundation Faculty Development Award
UNC Food Allergy Initiative
Thurston Arthritis Research Center
Arthur and Kayla Spector Charitable Fund
Article History
Received: 23 October 2025
Accepted: 10 November 2025
First Online: 29 November 2025
Declarations
:
: Any studies described in this review conducted by the authors were conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board of the University of North Carolina—Chapel Hill (UNC IRBs #16–1533 and #22–0893). Informed consent was obtained from all subjects involved in the study. Any animal studies described in this review were approved by the UNC Institutional Animal Care and Use Committee.
: Onyinye I. Iweala reports consultancies with Allakos, Techspert, and Blueprint Medicine; is a co-author on an industry-sponsored abstract and publication for Genentech; and is a site-PI for a clinical trial sponsored by Telios Pharma. All other authors declare that they have no conflict of interest.